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Background
Stevens-Johnson syndrome (SJS) and toxic epidermal
necrolysis (TEN), are severe cutaneous adverse drug
reactions that often induces the mucosal tissue impair-
ments. These symptoms in ocular surface sometimes
suffer the patients with pseudomembrane formation
leading to vision loss as a sequela. The purpose of this
study to reveal the medication tendencies for inducing
severe ocular surface complications in SJS/TEN of Japa-
nese populations.
Method
Japanese SJS/TEN patients were recruited through the
participating university/hospitals and nation-wide collect-
ing network (as JSAR research group) from June 2006 to
June 2013. Informations including patients’ backgrounds,
disease symptoms, and administered drugs before the
onset of SJS/TEN were also collected. Ocular symptoms
were graded as follows; 0; no complication, 1; only hypere-
mia of the bulbar and palpebral conjunctiva, 2; pseudo-
membrane formation, 3; defect of the conjunctiva or
corneal epithelia. The Grade 2 or 3 was grouped as severe
ocular surface complications.
Results
A total of 197 SJS/TEN patients were recruited; 97 males
and 100 females, average age 56.6} 22.3, 23, 115 and 59
for probable SJS, definite SJS and TEN, respectively, and
40, 95, 14 and 48 for eye symptom grade 0, 1, 2 and 3,
respectively. Females or young (below 60 years old)
patients show higher tendency for developing severe ocu-
lar symptoms but these comparisons did not reach the
statistical significance. In analysis on drugs or drug
groups that more than 14 patients were administered, the
SJS/TEN patients with acetaminophen showed signifi-
cantly higher rate (55.6%) of severe ocular symptoms
than those without this drug (28.0%) (p<0.01). The
patients with loxoprofen or cephalosporins exhibited the
same tendencies with borderline significance. In contrast,
no differences in the rates were observed for SJS/TEN
related to other drugs such as carbamazepine, allopuri-
nol, quinolones and aspirin. The patients receiving
NSAIDs for treatment of cold developed severe ocular
symptoms at the rate of 65.4%, while that in the patients
administered NSAIDs for other diseases was 17.1%.
Conclusion
In the Japanese population, we found that acetaminophen
or NSAIDs for treatment of cold showed high rates for
developing severe ocular complications. In addition to
skin, the SJS/TEN patients with these drugs should be
intensively treated for eye to prevent severe sequelae.
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